Signaling Pathways - MST - Nrf2 - HCV polymerase - Myosin light chain kinases (MLCKs)
清除全部
-
A8735 XMU-MP-12 CitationTarget: MSTSummary: MST1/2的强效选择性抑制剂 -
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂 -
B3576 Omaveloxolone (RTA-408)Target: Nrf2Summary: Nrf2激活剂 -
B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂 -
A3738 PSI-7977中文名: 索非布韦，索氟布韦Target: HCV polymeraseSummary: 慢性丙型肝炎病毒（HCV）感染的抗病毒剂 -
A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: 肌球蛋白轻链激酶抑制剂 -
A3335 Curcumin1 Citation中文名: 姜黄素Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|TyrosinasesSummary: Tyrosinase（酪氨酸酶）抑制剂 -
A3221 Bardoxolone methyl中文名: 甲基巴多索隆Target: Nrf2Summary: IKK抑制剂，强效的抗氧化炎性反应调节剂。 -
A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: HCV RNA聚合酶抑制剂 -
A8189 PSI-62063 CitationTarget: HCV polymeraseSummary: HCV RNA聚合酶抑制剂